GLP-1 Resource Center

GLP-1 Answer Hub

GLP-1 Resource Center

The questions GLP-1 patients actually ask.

GLP-1 medications like Ozempic, Wegovy, Mounjaro and Zepbound are clinically shown to support weight loss. What comes with them is a prescription, not a guide to the nutritional and physical consequences of eating significantly less. Your prescriber manages the medication. This resource covers the other half.

Each answer below explains the mechanism behind what you are experiencing and what the clinical evidence does and does not say about it. Where the research is thin, we say so. None of this replaces medical advice, and anything that concerns you belongs in front of your prescriber.

Nutrition and Supplements

Side Effects

Hair, Skin and Appearance

Muscle, Weight and Body Composition

Gut Health

Understanding Your Medication

Other Patients

Reference

TAKE was built around the needs these pages describe.* Seven Essentials, each formulated around one thing that commonly surfaces when food intake drops.* View The Essentials. Not sure where to start? Take the quiz.

These statements have not been evaluated by the Food and Drug Administration. TAKE products are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Always speak with your healthcare provider about medication side effects or medical concerns.
Ozempic® and Wegovy® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. References to these names on this page are for informational and descriptive purposes only and do not imply affiliation, sponsorship, or endorsement by, or partnership with, Novo Nordisk A/S, Eli Lilly and Company, or any other GLP-1 medication manufacturer.